Avita faces first strike
- {{x.value}}
{{ twilioFailed ? 'SMS Code Failed to Send…' : 'Enter verification code' }}
{{ completedStep1 ? 'Authentication & Security' : content.trialHeading.replace('{0}', user.FirstName) }}
{{ content.upgradeHeading.replace('{0}', user.FirstName) }}
The email address you entered is registered with InvestSMART
Please login to continue
We have sent you an email with the details of your registration.
Looks you are already a member. Please enter your password to proceed
{{ upgradeCTAText }}
Updating information
Please wait ...
Your membership to InvestSMART Group recently failed to renew.
Please make sure your payment details are up to date to continue your membership.
Having trouble renewing?
Please contact Member Services on support@investsmart.com.au or 1300 880 160
You've recently updated your payment details.
It may take a few minutes to update your subscription details, during this time you will not be able to view locked content.
If you are still having trouble viewing content after 10 minutes, try logging out of your account and logging back in.
Still having trouble viewing content?
Please contact Member Services on support@investsmart.com.au or 1300 880 160
Please click on the ACTIVATE button to activate your Intelligent Investor 15-day free trial
Please click on the ACTIVATE button to finalise your membership
Unsuccessful registration
Registration for this event is available only to Eureka Report members. View our membership page for more information.
Registration for this event is available only to Intelligent Investor members. View our membership page for more information.
- You are already registered for this event.
- This event is already full.
- Please select a quantity for at least one ticket.
- {{ i }}
Forgotten password
Please enter your email address below to request a new password
- Verify your email address by clicking on the link we sent to {{user.Email}}
- You now have free access, we look forward to helping you on your financial journey.
Avita Medical's two biggest shareholders say they will vote against the loss-making biotech's remuneration report, citing concerns over the pay of chief executive Bill Dolphin and company performance.
A strike will be recorded if more than 25 per cent of shares are voted against the rem report.
Australian Ethical Investments and Bioscience Managers control almost 28 per cent of Avita stock. If Avita records a second strike next year, it must ask shareholders if they wish to spill the board.
Bioscience Managers, which owns about 7.7 per cent of Avita, said it was likely Avita would need to raise capital in the year ahead.
"Shareholders are increasingly frustrated that a great technology is being poorly served by the management of the company," Bioscience Managers investment director Bronwyn Dilley said.
Australian Ethical Investments said it would vote its stake in Avita against the remuneration report.
Avita chairman Dalton Gooding said the company "welcomes feedback from all its shareholders".
Call 1300 880 160
Start a chat
Schedule a call
